Uncategorized

Locus Biosciences Enters Research Collaboration to Develop Precision Antibacterial Therapies for Ophthalmic Infections

by Business Wire • 2025/10/28 • 0 Comments

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- #AMR--Locus Biosciences announced a research collaboration with Viatris to develop engineered bacteriophage therapies for ophthalmic infections.

← Aldeyra Therapeutics Announces Positive Results from Phase 2 Clinical Trial in Alcohol-Associated Hepatitis, Focuses RASP Product Candidate Pipeline on Next-Generation Molecules

Targeted T-cell Therapy Beneficial in Rare Form of Melanoma →

Post navigation